Thyrocare Technologies
add_icon

Thyrocare Technologies

532.80
-15.15
(-2.76%)
Market Cap
8,480.33 Cr
PE Ratio
53.56
Volume
3,36,527.00
Day High - Low
559.00 - 530.00
52W High-Low
578.25 - 317.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
8,480.33 Cr
EPS
10.27
PE Ratio
53.56
PB Ratio
17.01
Book Value
32.21
EBITDA
279.00
Dividend Yield
2.56 %
Return on Equity
27.79
Debt to Equity
0.07
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Thyrocare Technologies filed its Business Responsibility and Sustainability Report for FY26. The report details ESG initiatives, including energy efficiency and waste management.
positive
Thyrocare Technologies submits FY 2025-26 Annual Report and 26th AGM Notice. Consolidated revenue rose to ₹829.04 crore; PAT surged to ₹162.85 crore. AGM scheduled June 30, 2026.
neutral
Docon Technologies disclosed annual encumbrance details for Thyrocare shares for FY26. The promoter group holds 60.93% of the total share capital under pledge.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,568.70
#1 26,284.36
51.80
#1 2,762.90
8.15
#1 510
-14.98
50.79
1,269.70
13,064.80
77.29
814.20
16.36
182
37.25
52.27
524.45
10,873.30
58.13
1,645.85
22.25
185
74.66
50.38
532.80
#4 8,480.33
#6 53.56
#5 846.00
#6 20.48
#4 163
#1 125.46
67.55
723.15
7,256.14
92.17
998.85
29.74
62
22.09
73.92
534.80
1,734.82
17.41
772.77
4.05
106
101.45
37.22
270.80
1,410.35
44.84
310.41
21.30
34
-13.89
39.10
576.30
1,126.28
#1 16.56
498.18
#1 237.06
69
65.45
64.77
1,253.40
1,075.75
17.28
141.92
27.17
61
22.50
53.49
286.50
911.37
-645.56
1,319.27
12.68
-3
-173.86
44.70
Growth Rate
Revenue Growth
20.48 %
Net Income Growth
79.41 %
Cash Flow Change
18.52 %
ROE
67.51 %
ROCE
30.10 %
EBITDA Margin (Avg.)
12.87 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
56
63
55
67
72
81
74
89
93
92
88
108
99
107
100
108
112
119
107
104
58
158
141
151
175
191
119
133
129
137
131
140
136
151
138
158
161
180
170
192
198
220
201
229
Expenses
37
36
35
41
42
64
51
60
53
53
49
60
56
61
61
71
64
64
62
77
48
91
89
95
94
87
81
93
92
103
100
111
100
111
103
121
115
129
124
130
135
145
144
149
EBITDA
20
26
20
27
30
17
23
30
39
39
39
48
43
46
39
37
48
55
45
26
9
67
52
55
81
104
38
40
37
33
31
29
36
40
35
37
46
51
46
62
63
75
57
80
Operating Profit %
34 %
39 %
36 %
38 %
39 %
18 %
28 %
32 %
39 %
40 %
42 %
39 %
42 %
41 %
37 %
33 %
42 %
45 %
41 %
24 %
15 %
40 %
36 %
35 %
43 %
51 %
31 %
29 %
28 %
23 %
22 %
18 %
26 %
25 %
23 %
22 %
27 %
27 %
25 %
30 %
30 %
33 %
26 %
34 %
Depreciation
5
4
5
5
4
4
5
5
4
5
5
6
6
7
7
7
7
8
8
9
7
8
8
8
7
8
9
10
9
9
10
11
10
11
14
13
11
13
17
14
11
12
22
14
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
-0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
-0
2
Profit Before Tax
17
25
19
22
26
13
19
25
35
34
34
42
38
39
32
29
40
46
37
18
2
59
44
48
74
95
29
30
28
24
20
17
25
28
20
23
34
37
28
47
51
63
35
64
Tax
6
9
8
8
9
11
9
9
13
10
12
17
14
14
12
13
13
11
9
19
2
16
12
10
18
18
7
9
6
8
5
5
8
8
5
6
10
10
9
26
12
15
7
16
Net Profit
11
16
11
14
17
1
9
15
22
25
22
25
23
25
20
16
28
35
28
-2
0
43
32
38
56
78
22
21
22
15
15
13
17
20
15
17
24
26
19
22
38
48
28
49
EPS in ₹
2.33
3.28
2.13
2.71
3.18
0.22
1.71
2.90
4.10
4.59
4.03
4.68
4.35
4.70
3.81
3.09
5.20
6.73
5.21
-0.30
0.04
8.15
6.13
7.14
10.51
14.70
4.05
4.04
4.11
3.80
2.78
2.36
3.26
3.84
2.78
3.54
4.52
4.99
3.58
4.17
7.35
9.05
1.82
2.99

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
329
410
438
479
475
471
546
608
633
644
693
747
Fixed Assets
196
259
259
299
294
269
253
285
294
306
297
317
Current Assets
111
134
150
142
136
152
240
270
273
279
338
372
Capital Work in Progress
6
1
17
0
2
5
8
3
2
3
14
3
Investments
84
92
104
120
95
90
126
146
144
162
162
177
Other Assets
43
58
58
60
84
107
159
174
193
173
220
250
Total Equity & Liabilities
329
410
438
479
475
471
546
608
633
644
693
747
Current Liabilities
7
31
18
20
21
82
95
65
77
91
122
110
Non Current Liabilities
10
13
12
15
19
23
23
17
20
26
24
51
Total Equity
312
366
408
443
435
367
427
527
535
528
547
586
Reserve & Surplus
226
312
354
390
382
314
374
474
463
440
439
354
Share Capital
51
54
54
54
53
53
53
53
53
53
53
159

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-6
5
-1
-0
-5
4
5
0
4
-9
8
21
Investing Activities
-18
-18
-42
-43
-12
1
-49
-24
-39
-91
-41
-23
Operating Activities
35
68
90
107
100
168
115
113
129
168
180
213
Financing Activities
-23
-45
-49
-64
-94
-165
-62
-89
-86
-85
-130
-170

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
66.14 %
66.14 %
71.22 %
71.18 %
71.18 %
71.18 %
71.14 %
71.14 %
71.14 %
71.14 %
71.14 %
71.11 %
71.11 %
71.11 %
71.11 %
71.06 %
71.06 %
71.06 %
71.06 %
60.93 %
60.92 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.46 %
0.00 %
2.90 %
2.49 %
1.93 %
2.77 %
2.41 %
3.23 %
4.85 %
4.95 %
5.37 %
DIIs
7.14 %
6.17 %
6.07 %
6.37 %
6.52 %
6.68 %
8.66 %
8.69 %
8.45 %
13.46 %
13.33 %
13.55 %
14.88 %
14.90 %
14.80 %
14.67 %
14.97 %
14.54 %
13.47 %
20.51 %
20.99 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.01 %
6.32 %
7.60 %
7.44 %
6.65 %
6.71 %
7.28 %
8.07 %
8.38 %
9.42 %
9.66 %
9.15 %
8.48 %
8.66 %
9.78 %
9.16 %
9.21 %
8.94 %
8.19 %
10.88 %
10.18 %
Others
21.71 %
21.37 %
15.11 %
15.01 %
15.66 %
15.43 %
12.91 %
12.10 %
12.03 %
5.97 %
2.42 %
6.19 %
2.63 %
2.84 %
2.38 %
2.33 %
2.36 %
2.23 %
2.43 %
2.73 %
2.53 %
No of Share Holders
0
44,722
53,140
62,936
65,769
66,315
66,431
71,412
74,386
76,292
72,000
68,844
64,823
61,636
59,377
56,666
57,403
54,566
54,142
77,969
73,377

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 10 10 20 5 25 15 18 18 21 14
Dividend Yield (%) 5.03 5.62 12.08 1.66 9.67 10.47 9.15 7.95 6.01 2.55

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Jun 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jun 2026 521.45 547.95
23 Jun 2026 DIVIDEND Dividend
₹ 7.00 /share
23 Jun 2026 460.60 547.95
19 Jun 2021 DIVIDEND Dividend
₹ 15.00 /share
17 Jun 2021 353.00 429.26
12 May 2022 DIVIDEND Dividend
₹ 15.00 /share
11 May 2022 270.30 245.00
20 Apr 2023 DIVIDEND Dividend
₹ 18.00 /share
20 Apr 2023 148.73 168.13
16 Aug 2024 DIVIDEND Dividend
₹ 18.00 /share
16 Aug 2024 206.43 293.18
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 272.66 297.06
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 275.41 295.60
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 275.35 269.23
23 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Apr 2025 234.33 265.03
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jul 2025 387.83 395.83
25 Jul 2025 DIVIDEND Dividend
₹ 21.00 /share
25 Jul 2025 265.03 445.68
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 341.05 433.45
14 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Oct 2025 392.83 420.53
24 Oct 2025 DIVIDEND Dividend
₹ 7.00 /share
24 Oct 2025 420.53 417.76
28 Nov 2025 BONUS Bonus
2:1
28 Nov 2025 521.33 491.30
28 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2026 476.15 453.25
07 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 May 2026 406.60 460.60

Announcements

Communication To Shareholders - Intimation On Tax Deduction On Dividend3 hrs ago
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Letter Sent To Members Of The Company Providing Web Link For AGM Notice And Annual Report For The FY 2025-266 days ago
Record Date For The Purpose Of Final Dividend For The FY 2025-26 Is Tuesday June 23 20266 days ago
Business Responsibility and Sustainability Reporting (BRSR)6 days ago
Reg. 34 (1) Annual Report.6 days ago
Notice Of 26Th Annual General Meeting Of Thyrocare Technologies Limited To Be Held On Tuesday June 30 2026 At 11:00 A.M. (IST)6 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 07, 2026
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMay 07, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMay 07, 2026
Appointment Of Cost Auditors For The Financial Year 2026-27May 07, 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 07, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 07, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 07, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 07, 2026
Corporate Action-Board approves DividendMay 07, 2026
Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended On March 31 2026May 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 07, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 07, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 07 2026May 07, 2026
Cancellation Of Earning Conference CallMay 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 29, 2026
Corporate Action-Board to consider DividendApr 29, 2026
Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Recommendation Of The Final Dividend If Any For The Financial Year 2Apr 29, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 25, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 29, 2026
Closure of Trading WindowMar 23, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 02, 2026
Announcement under Regulation 30 (LODR)-AcquisitionFeb 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 28, 2026
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jan 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 28, 2026
Financial Results For The Quarter And Nine Months Ended December 31 2025.Jan 28, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On January 28 2026 Jan 28, 2026
Press Release - Thyrocare Onboards Madhuri Dixit As The Brand Ambassador To Inspire Health And Well-Being Across IndiaJan 27, 2026
Intimation Of Receipt Of AwardsJan 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 20, 2026
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31 2025Jan 20, 2026
Change Of Name Of M S K A & Associates Upon Conversion Of Firm Into LLPJan 17, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
0.00%
-10000
-0.14%
0.00%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-186
-0.01%
-0.01%
ICICI Prudential India Opportunities Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Innovation Fund Direct-Growth
1.16%
0
0.00%
0.17%
Angel One Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-0.18%
Aditya Birla Sun Life ELSS Tax Saver Direct-Growth
0.00%
0
0.00%
-0.93%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.01%
DSP Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
DSP India T.I.G.E.R. (The Infrastructure Growth and Economic Reforms Fund) Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.01%
HDFC Innovation Fund Direct-Growth
1.34%
0
0.26%
0.29%
HDFC Pharma And Healthcare Fund Direct-Growth
1.54%
0
0.00%
0.21%
HSBC Large and Mid Cap Fund Direct-Growth
0.00%
0
0.00%
-1.43%
HSBC Midcap Fund Direct-Growth
0.00%
0
0.00%
-1.31%
ICICI Prudential Active Momentum Fund Direct-Growth
1.19%
0
0.21%
0.22%
ICICI Prudential Dividend Yield Equity Fund Direct-Growth
1.69%
0
0.00%
0.35%
ICICI Prudential Exports and Services Fund Direct-Growth
0.45%
0
0.00%
0.09%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
0.00%
0
0.00%
-1.58%
Aditya Birla Sun Life Bal Bhavishya Yojna Direct-Growth
0.00%
0
0.00%
-0.95%
ICICI Prudential Multicap Fund Direct Plan-Growth
0.38%
0
0.00%
0.07%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth
2.40%
0
0.00%
0.52%
ICICI Prudential Quality Fund Direct-Growth
0.00%
0
0.00%
0.00%
JioBlackRock Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.01%

Technical Indicators

RSI(14)
Neutral
76.36
ATR(14)
Volatile
22.49
STOCH(9,6)
Overbought
83.67
STOCH RSI(14)
Overbought
89.73
MACD(12,26)
Bullish
2.23
ADX(14)
Very Strong Trend
52.34
UO(9)
Bearish
62.57
ROC(12)
Uptrend And Accelerating
16.82
WillR(14)
Neutral
-25.65